Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92021002 | 9202100 | 2 | F | 2006 | 20160830 | 20130327 | 20160906 | EXP | US-ELI_LILLY_AND_COMPANY-US201303006179 | ELI LILLY AND CO | 0.00 | M | Y | 0.00000 | 20160906 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92021002 | 9202100 | 1 | PS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | 60 MG, QD | Y | 21427 | 60 | MG | CAPSULE | QD | |||||
| 92021002 | 9202100 | 2 | SS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 30 MG, QD | Y | 21427 | 30 | MG | CAPSULE | QD | ||||||
| 92021002 | 9202100 | 3 | SS | DULOXETINE HYDROCHLORIDE. | DULOXETINE HYDROCHLORIDE | 1 | Unknown | UNK, UNKNOWN | 0 | 60 | MG | QD | |||||||
| 92021002 | 9202100 | 4 | C | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 92021002 | 9202100 | 5 | C | CLONOPIN | CLONAZEPAM | 1 | Unknown | UNK, UNKNOWN | U | U | 0 | ||||||||
| 92021002 | 9202100 | 6 | C | GEODON | ZIPRASIDONE HYDROCHLORIDEIPRASIDONE MESYLATE | 1 | Unknown | UNK, UNKNOWN | U | U | 0 | ||||||||
| 92021002 | 9202100 | 7 | C | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | Unknown | UNK, UNKNOWN | U | U | 0 | ||||||||
| 92021002 | 9202100 | 8 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Unknown | UNK, UNKNOWN | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 92021002 | 9202100 | 1 | Neuralgia |
| 92021002 | 9202100 | 3 | Neuralgia |
| 92021002 | 9202100 | 5 | Seizure |
| 92021002 | 9202100 | 6 | Product used for unknown indication |
| 92021002 | 9202100 | 7 | Product used for unknown indication |
| 92021002 | 9202100 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 92021002 | 9202100 | OT |
| 92021002 | 9202100 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 92021002 | 9202100 | Abdominal pain upper | |
| 92021002 | 9202100 | Diabetes mellitus | |
| 92021002 | 9202100 | Drug withdrawal headache | |
| 92021002 | 9202100 | Drug withdrawal syndrome | |
| 92021002 | 9202100 | Fall | |
| 92021002 | 9202100 | Gastric haemorrhage | |
| 92021002 | 9202100 | Intentional product misuse | |
| 92021002 | 9202100 | Loss of consciousness | |
| 92021002 | 9202100 | Paraesthesia | |
| 92021002 | 9202100 | Suicidal ideation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 92021002 | 9202100 | 1 | 2004 | 0 | ||
| 92021002 | 9202100 | 3 | 2015 | 0 |